Dentsply Sirona (XRAY) closed at $9.43 on October 23, 2026, down 0.7% from the previous close, on volume of 3,380,489 shares (30-day average 4,809,636).
Data as of October 23, 2026.
23-Oct-2026
Globe Newswire (Wed, 7-Oct 8:34 AM ET)
Dentsply Sirona Continues North American Commercial Expansion with Midwest Dental Agreement
Globe Newswire (Tue, 6-Oct 9:07 AM ET)
Business Wire (Fri, 11-Sep 8:00 AM ET)
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Mon, 7-Sep 3:32 PM ET)
Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference
Globe Newswire (Thu, 3-Sep 4:15 PM ET)
PRNewswire (Wed, 19-Aug 8:30 AM ET)
Dentsply Sirona Reports Second Quarter 2026 Results
Globe Newswire (Thu, 6-Aug 4:01 PM ET)
Globe Newswire (Tue, 28-Jul 8:30 AM ET)
XRAY Appoints John Fortson as CFO: Leadership Experience Signals Focus on Growth and Efficiency
Market Chameleon (Fri, 12-Jun 7:46 AM ET)
Dentsply Sirona’s Upcoming Conference Appearance Highlights Strategic Position in Dental Technology
Market Chameleon (Wed, 4-Mar 2:33 AM ET)
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantology. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers.
Dentsply Sirona trades on the NASDAQ stock market under the symbol XRAY.
As of October 23, 2026, XRAY stock price declined to $9.43 with 3,380,489 million shares trading.
XRAY has a beta of 1.03, meaning it tends to be more sensitive to market movements. XRAY has a correlation of 0.07 to the broad based SPY ETF.
XRAY has a market cap of $1.89 billion. This is considered a Small Cap stock.
Last quarter Dentsply Sirona reported $898 million in Revenue and $.52 earnings per share. This beat revenue expectation by $11 million and exceeded earnings estimates by $.17.
In the last 3 years, XRAY traded as high as $37.60 and as low as $8.32.
The top ETF exchange traded funds that XRAY belongs to (by Net Assets): IJH, VTI, IWM, VB, VBR.
XRAY has underperformed the market in the last year with a return of -27.1%, while the SPY ETF gained +14.3%. In the last 3 month period, XRAY fell short of the market, returning -25.9%, while SPY returned +3.2%. However, in the most recent 2 weeks XRAY has outperformed the stock market by returning +6.8%, while SPY returned -2.4%.
XRAY support price is $9.25 and resistance is $9.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XRAY shares will trade within this expected range on the day.
